ILF2
ILF2 (interleukin enhancer binding factor 2), also known as NF45, is a 45 kDa nuclear protein that acts as a transcription factor for T-cell expression of the interleukin 2 gene. It also binds RNA and partners with ILF3 in several nucleic acid pathways. Browse Assay Genie's current range of ILF2 research reagents below, or read on for the biology behind the target.
ILF2 is a transcription factor required for T-cell expression of the interleukin 2 gene. It also binds RNA. In complex with the 90 kDa interleukin enhancer-binding factor 3 (ILF3, also called NF90), the 45 kDa ILF2 protein has been shown to affect the redistribution of nuclear mRNA to the cytoplasm, to repair DNA breaks by nonhomologous end joining, and to negatively regulate the microRNA processing pathway.
The ILF2 protein is found in the nucleus, including the nucleolus, and in the cytoplasm, which fits its roles in both transcription and RNA handling. Knockdown of NF45 or NF90 retards cell growth, possibly through inhibition of mRNA stabilisation. The ILF2 gene undergoes alternative splicing, giving multiple transcript variants, and related pseudogenes lie on chromosomes 3 and 14. Mouse and rat both carry an Ilf2 ortholog.
ILF2 also features in viral biology. It is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. In HIV-1 infection, ILF2 plays a positive role in virus production by binding to and stabilising HIV-1 RNA, together with ILF3. The name reflects the original description of the factor as an interleukin enhancer binder, and earlier HGNC names specified the 45 kDa size.
ILF2 is a transcription factor required for T-cell expression of the interleukin 2 gene, making it relevant to studies of cytokine gene control.
The ILF2–ILF3 complex affects nuclear mRNA redistribution to the cytoplasm and negatively regulates the microRNA processing pathway.
The ILF2–ILF3 complex has been shown to repair DNA breaks by nonhomologous end joining.
ILF2 supports hepatitis B polymerase encapsidation and priming, and stabilises HIV-1 RNA with ILF3 to promote virus production.
ILF2 is a transcription factor required for T-cell expression of the interleukin 2 gene, and it also binds RNA. With ILF3 it affects nuclear mRNA redistribution, DNA break repair by nonhomologous end joining and microRNA processing. Check the datasheet of any product for its validated reactivity.
ILF2 is also known as NF45, reflecting its size of about 45 kDa. Earlier HGNC names were interleukin enhancer binding factor 2, 45kD and 45kDa. Its partner ILF3 is called NF90. Alternative splicing of the ILF2 gene produces multiple transcript variants.
Mouse and rat each have an Ilf2 ortholog. ILF2 is implicated in viral processes: it is needed for hepatitis B polymerase encapsidation and priming, and with ILF3 it binds and stabilises HIV-1 RNA, promoting virus production.
ILF3, the NF90 partner of ILF2, and related targets in RNA processing and transcription research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q12905; product specifications from Assay Genie datasheets.